Jan 26, 2016 7:00 am EST Heat Biologics CSO to Present Interim Results From the Monotherapy Arm in Its Ongoing HS-410 Phase 2 Bladder Cancer Trial at the Phacilitate Immunotherapy World Conference
Nov 18, 2015 7:00 am EST Heat Biologics Selected as One of Informa's 2015 Top 10 Immuno-Oncology Companies to Watch
Nov 06, 2015 7:00 am EST Heat Biologics Reports HS-410 Phase 1 Bladder Cancer Trial Results at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 03, 2015 8:00 am EST Results of Heat Biologics' HS-410 Phase 1 Safety Trial in Non-Muscle Invasive Bladder Cancer to be Presented at SITC Annual Meeting
Oct 14, 2015 7:00 am EDT Heat Biologics Expands Scientific and Clinical Advisory Board With Appointments of Drs. Holbrook Kohrt and Kapil Dhingra
Oct 08, 2015 7:00 am EDT Heat Biologics Completes Patient Enrollment for Randomized Arms of Its Phase 2 HS-410 Bladder Cancer Trial